Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a site version update. The change does not modify study information or other visible content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3 on the page. This reflects a metadata/version update rather than a substantive change to study details.SummaryDifference0.0%

- Check55 days agoChange DetectedEnrollment status was updated to indicate no participant recruitment is currently ongoing. New user-focused sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and a revision note (Revision: v3.6.0) was included.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a behind-the-scenes update to the site; no study information or results are affected.SummaryDifference0.0%

- Check83 days agoChange DetectedThe revision history now lists a new Revision: v3.5.4, replacing the previous Revision: v3.5.3.SummaryDifference0.0%

- Check105 days agoChange DetectedThe page’s footer revision label has been updated from version v3.5.2 to v3.5.3, indicating a minor platform/version update rather than a change to the study content.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.